share_log

New Fortress Energy And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via news ·  May 19 11:23

(VIANEWS) – New Fortress Energy (NFE), AMETEK (AME), RadNet (RDNT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. New Fortress Energy (NFE)

35.2% sales growth and 34.1% return on equity

New Fortress Energy Inc. operates as an integrated gas-to-power energy infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. The Ships segment offers floating storage and regasification units (FRSU) and liquefied natural gas (LNG) carriers which are leased to customers under long-term or spot arrangements. The company operates LNG storage and regasification facility at the Port of Montego Bay, Jamaica; marine LNG storage and regasification facility in Old Harbour, Jamaica; Dual-fired combined heat and power facility in Clarendon, Jamaica; landed micro-fuel handling facility in San Juan, Puerto Rico; and LNG receiving facility and gas-fired power plant in Baja Califrnia Sur, Mexico, as well as a Miami facility. New Fortress Energy Inc. was founded in 1998 and is based in New York, New York.

Earnings Per Share

As for profitability, New Fortress Energy has a trailing twelve months EPS of $2.65.

PE Ratio

New Fortress Energy has a trailing twelve months price to earnings ratio of 10.1. Meaning, the purchaser of the share is investing $10.1 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.1%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 38.8%, now sitting on 2.41B for the twelve trailing months.

Volume

Today's last reported volume for New Fortress Energy is 358400 which is 74.54% below its average volume of 1408060.

2. AMETEK (AME)

12.9% sales growth and 15.77% return on equity

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers; and operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.

Earnings Per Share

As for profitability, AMETEK has a trailing twelve months EPS of $5.67.

PE Ratio

AMETEK has a trailing twelve months price to earnings ratio of 31.69. Meaning, the purchaser of the share is investing $31.69 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.77%.

3. RadNet (RDNT)

8.6% sales growth and 6.37% return on equity

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Earnings Per Share

As for profitability, RadNet has a trailing twelve months EPS of $0.37.

PE Ratio

RadNet has a trailing twelve months price to earnings ratio of 155.27. Meaning, the purchaser of the share is investing $155.27 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.37%.

4. HCA Holdings (HCA)

6% sales growth and 845.54% return on equity

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Earnings Per Share

As for profitability, HCA Holdings has a trailing twelve months EPS of $18.98.

PE Ratio

HCA Holdings has a trailing twelve months price to earnings ratio of 17.01. Meaning, the purchaser of the share is investing $17.01 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 845.54%.

Yearly Top and Bottom Value

HCA Holdings's stock is valued at $322.82 at 11:22 EST, under its 52-week high of $335.83 and way higher than its 52-week low of $215.96.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 66.72B for the twelve trailing months.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 12.8% and 15.3%, respectively.

Sales Growth

HCA Holdings's sales growth for the next quarter is 6%.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment